ECOLAB INC. ECL

Healthcare SIC 2840 - Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics NYSE

General Development of Business.

Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31. International subsidiaries are included in the consolidated financial statements on the basis of their U.S. GAAP (accounting principles generally accepted in the United States of America) November 30 fiscal year ends to facilitate the timely inclusion of such entities in our consolidated financial reporting.

Narrative Description of Business.

A trusted partner for millions of customers, we are a global leader in water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. For more than a century, we have advanced innovation by integrating science-based solutions, data-driven insights, AI-technology and world-class service. This unique combination enables us to partner with customers to define what best-in-class looks like and scale it across their operations, helping them achieve peak performance. Today, we have $16 billion in annual sales, 48,000 associates and customers in more than 170 countries and 40 industries. We help protect one-third of the world's food production and a quarter of the power generated while delivering innovative solutions across food, healthcare, data centers, microelectronics, life sciences and hospitality. Our comprehensive approach protects what's vital, aiming by 2030 to help protect 2 billion people from infections and enough drinking water for 1 billion people while enhancing business performance.

Last close 279.28 2026-09-04
Market cap $78.29B 2026-06-30 share count
52-week range 243.15 - 309.27

Valuation FY2025 figures against the last close

P/S4.9x
P/E38.4x
P/FCF41.1x
EV/EBITDA23.0x
Dividend yield1.0%
Diluted EPS7.28

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $16.08B$15.74B$15.32B$14.19B$12.73B$11.79B$12.56B$12.22B$11.53B$13.15B
Cost of revenue $8.93B$8.90B$9.15B$8.83B$7.62B$6.91B$7.05B$6.88B$6.41B$7.53B
Gross profit $7.15B$6.84B$6.17B$5.36B$5.12B$4.88B$5.52B$5.35B$5.12B$5.62B
R&D $202.0M$207.0M$192.0M$190.0M$186.0M$185.0M$190.0M$193.0M$177.0M$189.0M
SG&A $4.26B$4.23B$4.06B$3.65B$3.42B$3.31B$3.55B$3.51B$3.36B$3.71B
Operating income $2.74B$2.80B$1.99B$1.56B$1.60B$1.40B$1.85B$1.73B$1.75B$1.87B
Interest expense $306.2M$340.3M$348.9M$252.1M$230.6M$304.8M$214.4M$235.5M$272.2M$285.4M
Pre-tax income $2.55B$2.57B$1.76B$1.34B$1.41B$1.16B$1.73B$1.59B$1.56B$1.65B
Income tax $454.6M$439.3M$362.5M$234.5M$270.2M$176.6M$288.6M$321.2M$189.8M$402.9M
Net income $2.08B$2.11B$1.37B$1.09B$1.13B-$1.19B$1.58B$1.44B$1.52B$1.25B
EPS, basic 7.337.434.823.833.95-4.205.414.955.204.20
EPS, diluted 7.287.374.793.813.91-4.155.334.885.124.14
Shares, diluted (wtd. avg.) $285.2M$286.6M$286.5M$286.6M$289.1M$290.3M$292.5M$292.8M$294.0M$296.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $646.2M$1.26B$919.5M$598.6M$359.9M$1.26B$118.8M$243.2M$163.3M$380.4M
Receivables $3.25B$2.87B$2.83B$2.70B$2.48B$2.27B$2.38B$2.66B$2.57B$2.34B
Inventory $1.49B$1.46B$1.50B$1.79B$1.49B$1.29B$1.08B$1.55B$1.45B$1.32B
Total current assets $5.96B$6.03B$5.64B$5.49B$4.69B$5.12B$4.83B$4.68B$4.59B$4.28B
Property, plant and equipment $4.28B$3.75B$3.47B$3.29B$3.29B$3.12B$3.23B$3.84B$3.71B$3.37B
Goodwill $9.23B$7.91B$8.15B$8.01B$8.06B$6.01B$5.57B$5.39B$7.17B$6.38B
Other intangibles $3.69B$3.31B$3.49B$3.68B$4.22B$2.98B$2.93B$3.80B$4.02B$3.82B
Total assets $24.70B$22.39B$21.85B$21.46B$21.21B$18.13B$20.87B$20.07B$19.96B$18.33B
Accounts payable $2.07B$1.81B$1.57B$1.73B$1.38B$1.16B$1.08B$1.26B$1.18B$983.2M
Short-term debt $870.4M$615.7M$630.4M$505.1M$411.0M$17.3M$380.5M$743.6M$564.4M$541.3M
Total current liabilities $5.53B$4.79B$4.35B$4.21B$3.55B$2.93B$3.63B$3.69B$3.48B$3.02B
Total liabilities $14.89B$13.60B$13.77B$14.21B$13.95B$11.92B$12.14B$12.02B$12.31B$11.36B
Retained earnings $12.83B$11.52B$10.08B$9.32B$8.81B$8.24B$9.99B$8.91B$8.01B$6.97B
Total equity $9.77B$8.76B$8.07B$7.26B$7.25B$6.20B$8.73B$8.05B$7.65B$6.94B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $2.95B$2.81B$2.41B$1.79B$2.06B$1.86B$2.42B$2.28B$2.09B$1.94B
Depreciation and amortisation $672.6M$634.9M$616.7M$618.5M$604.4M$594.3M$569.1M$535.9M$500.1M$561.0M
Stock-based compensation $136.6M$134.8M$95.1M$87.8M$89.5M$82.1M$84.0M$88.0M$85.5M$85.7M
Capital expenditure $1.05B$994.5M$774.8M$712.8M$643.0M$489.0M$731.3M$778.7M$787.4M$756.8M
Investing cash flow -$2.71B-$433.8M-$990.5M-$716.8M-$4.58B-$414.5M-$1.20B-$1.03B-$1.73B-$773.6M
Financing cash flow -$853.3M-$2.02B-$1.05B-$837.3M$1.60B-$341.8M-$1.35B-$1.17B-$522.7M-$868.2M
Dividends paid $753.6M$664.3M$617.3M$602.8M$566.4M$560.8M$552.9M$494.8M$443.4M$427.5M
Buybacks $783.8M$986.5M$13.7M$518.2M$106.6M$146.2M$353.7M$562.4M$600.3M$739.6M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-018357.

Others in SIC 2840

TickerCompanyMarket capP/ERevenue growth
PG PROCTER & GAMBLE Co $340.39B 22.1x 3.3%
CHD CHURCH & DWIGHT CO INC /DE/ $23.38B 32.6x 1.6%
SCL STEPAN CO $1.44B 30.9x 7.0%
UL UNILEVER PLC
WNW Meiwu Technology Co Ltd 4,368.0%
BYAH Park Ha Biological Technology Co., Ltd. 6.0%